Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Mingchen Health Co.,Ltd. (002919.SZ)
Shantou, CN
Established in 1994 and headquartered in Shantou, China, Mingchen Health Co., Ltd. is a key player in the Chinese personal care sector. The company's core activities involve the research, manufacturing, and distribution of a variety of personal health and hygiene products. Its offerings notably include hair care solutions such as anti-dandruff shampoos and conditioners, as well as an assortment of skincare lotions. These items are sold under a portfolio of brands, including Did Flower Show, MeiWang, YiCai, High-tech Health, Green effect, and Likoujian. The company was formerly known as Guangdong Ming Chen Co., Ltd. before its current rebranding.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.99% | -11.72% | -3.83% | -18.82% | -2.96% | -1.70% | +42.77% | -21.96% | -2.80% | +309.42% | +309.42% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+9.7% ★ Q1'26: +15.5% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-38.9% Q1'26: -31.2% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+5.5% Q1'26: +0.5% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+3.7% Q1'26: +1.3% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+6.0% Q1'26: +3.8% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+2.7% Q1'26: +4.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×1.28× ★ Q1'26: 4.58× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|
| Revenue |
760.00M
est.
|
744.15M
est: 1.07B (-30.3%)
|
945.40M
est: 2.22B (-57.5%)
|
1.64B
est: 2.22B (-26.3%)
|
1.38B
est: 2.60B (-46.8%)
|
1.51B
est: 2.94B (-48.5%)
|
| EBITDA |
101.61M
est.
|
147.23M
est: 142.79M (+3.1%)
|
54.36M
est: 297.22M (-81.7%)
|
205.60M
est: 297.22M (-30.8%)
|
57.24M
est: 246.35M (-76.8%)
|
79.20M
est: 279.10M (-71.6%)
|
| EBIT |
61.15M
est.
|
129.22M
est: 85.93M (+50.4%)
|
17.20M
est: 178.87M (-90.4%)
|
60.31M
est: 178.87M (-66.3%)
|
29.06M
est: 148.60M (-80.4%)
|
55.43M
est: 168.36M (-67.1%)
|
| Net Income |
162.58M
est.
|
133.49M
est: 113.14M (+18.0%)
|
25.39M
est: 343.91M (-92.6%)
|
70.36M
est: 343.91M (-79.5%)
|
46.72M
est: 635.29M (-92.6%)
|
28.31M
est: 713.03M (-96.0%)
|
| SGA |
204.83M
est.
|
152.59M
est: 287.84M (-47.0%)
|
400.32M
est: 599.12M (-33.2%)
|
772.95M
est: 599.12M (+29.0%)
|
546.54M
est: 980.11M (-44.2%)
|
593.64M
est: 1.11B (-46.5%)
|
| EPS |
0.63
est.
|
0.50
est: 0.44 (+14.7%)
|
0.09
est: 1.33 (-93.1%)
|
0.26
est: 1.33 (-80.4%)
|
0.18
est: 2.38 (-92.4%)
|
0.11
est: 2.68 (-95.9%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-28 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-27 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-25 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dongsong Chen | Secretary of the Board, Deputy GM & Non-Independent Director | — | male |
| Fengling Cui | Supervisor & Manager of Technical Department | — | female |
| Jianming Chen | Chairman & GM | — | male |
| Xiaoqing Peng | Vice Chairman, Deputy GM & Chief Financial Officer | — | male |
| Yaolin Lin | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002919.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
